McGevna Moira A, Ratner Molly, Rockman Caron B, Maldonado Thomas S, Harish Keerthi B, Hingorani Anil, Jacobowitz Glenn R, Sadek Mikel, Berland Todd, Garg Karan
Division of Vascular Surgery and Endovascular Therapy, Rutgers Robert Wood Johnson Medical School, Piscataway, NJ.
Division of Vascular and Endovascular Therapy, New York University Langone Health, New York, NY.
J Vasc Surg Venous Lymphat Disord. 2025 Jun 6;13(5):102277. doi: 10.1016/j.jvsv.2025.102277.
Patients presenting with iliofemoral deep venous thrombosis (DVT) often undergo percutaneous thrombectomy intending to prevent post-thrombotic syndrome. However, the relationship between the extent of DVT and outcomes after thrombectomy has not been explored. The objective of this study was to compare rates of post-thrombectomy DVT recurrence between patients with isolated iliofemoral DVT and patients with iliofemoral DVT and extension more peripherally.
We conducted a single-center, retrospective analysis of all patients who underwent thrombectomy for iliofemoral DVT from 2014 to 2023. Patients were stratified into two cohorts: (1) iliofemoral DVT without popliteal/tibial extension or (2) iliofemoral DVT with popliteal/tibial extension. The primary outcome was acute DVT recurrence and multivariable analysis was performed to identify risk factors for recurrence. The χ test and t test were calculated for categorical and continuous data, respectively. Kaplan-Meier analysis was used to compare rates of acute DVT and chronic venous changes postoperatively. A P value of <.05 was considered statistically significant.
We identified 222 patients during the study period (76 isolated iliofemoral DVT vs 146 iliofemoral DVT with peripheral extension) with a median follow-up of 19 months. Patients who presented with iliofemoral DVT with peripheral extension were more likely to be older (57 years vs 50 years; P = .004), have hypertension (64% vs 41%; P = .001) or hyperlipidemia (58% vs 40%; P = .01), and to have had surgery within the prior 6 months (29% vs 17%; P = .04). Among the female patients, those on hormone therapy were more likely to have isolated iliofemoral DVT (17% vs 3%; P < .001). Patients with iliofemoral DVT with peripheral extension had a greater chance of developing recurrent acute DVT (48% vs 20%; P < .001) and chronic venous changes (51% vs 30%; P = .004) during follow-up. Multivariable analysis showed a significant correlation between iliofemoral DVT with peripheral extension (odds ratio, 3.8; 95% confidence interval, 1.7-8.7; P = .001) and acute DVT recurrence. There were no differences in the rates of reintervention or death.
A more extensive peripheral thrombus burden was associated with higher rates of follow-up DVT recurrence in patients undergoing thrombectomy for iliofemoral DVT. These findings suggest that such patients may require closer follow-up and more aggressive anticoagulation therapy postoperatively. Moreover, our results provide a framework for further studies to specifically study the role peripheral thrombus may play in venous hemodynamics and the development of recurrent DVT and, ultimately, post-thrombotic syndrome.
出现髂股深静脉血栓形成(DVT)的患者常接受经皮血栓切除术,旨在预防血栓形成后综合征。然而,DVT范围与血栓切除术后结局之间的关系尚未得到探究。本研究的目的是比较孤立性髂股DVT患者与伴有更外周延伸的髂股DVT患者血栓切除术后DVT复发率。
我们对2014年至2023年期间所有接受髂股DVT血栓切除术的患者进行了单中心回顾性分析。患者被分为两个队列:(1)无腘静脉/胫静脉延伸的髂股DVT或(2)伴有腘静脉/胫静脉延伸的髂股DVT。主要结局是急性DVT复发,并进行多变量分析以确定复发的危险因素。分别对分类数据和连续数据计算χ检验和t检验。采用Kaplan-Meier分析比较术后急性DVT和慢性静脉变化的发生率。P值<.05被认为具有统计学意义。
在研究期间,我们确定了222例患者(76例孤立性髂股DVT与146例伴有外周延伸的髂股DVT),中位随访时间为19个月。伴有外周延伸的髂股DVT患者更可能年龄较大(57岁对50岁;P =.004)、患有高血压(64%对41%;P =.001)或高脂血症(58%对40%;P =.01),并且在过去6个月内接受过手术(29%对17%;P =.04)。在女性患者中,接受激素治疗的患者更可能患有孤立性髂股DVT(17%对3%;P <.001)。伴有外周延伸的髂股DVT患者在随访期间发生复发性急性DVT(48%对20%;P <.001)和慢性静脉变化(51%对30%;P =.004)的可能性更大。多变量分析显示伴有外周延伸的髂股DVT(比值比,3.8;95%置信区间,1.7 - 8.7;P =.001)与急性DVT复发之间存在显著相关性。再次干预率或死亡率无差异。
对于接受髂股DVT血栓切除术的患者,更广泛的外周血栓负荷与更高的随访DVT复发率相关。这些发现表明,此类患者术后可能需要更密切的随访和更积极的抗凝治疗。此外,我们的结果为进一步研究提供了一个框架,以具体研究外周血栓在静脉血流动力学以及复发性DVT和最终血栓形成后综合征发展中可能发挥的作用。